Eric Morgen - 17 Apr 2024 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Chief Operating Officer, Director
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Issuer symbol
BIOA
Transactions as of
17 Apr 2024
Net transactions value
$0
Form type
4
Filing time
27 Sep 2024, 16:17:00 UTC
Next filing
25 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOA Stock Option (Right to Buy) Award $0 +4,952 $0.000000 4,952 25 Sep 2024 Common Stock 4,952 $18.00 By Spouse F1, F2
transaction BIOA Stock Option (Right to Buy) Award $0 +257,973 $0.000000 257,973 17 Apr 2024 Common Stock 257,973 $8.39 Direct F3, F4
transaction BIOA Stock Option (Right to Buy) Award $0 +13,598 $0.000000 13,598 17 Apr 2024 Common Stock 13,598 $8.39 By Spouse F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest as to 1/48th of the total award monthly, with the first tranche vesting on October 1, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F2 Represents an employee stock option directly held by the reporting person's spouse.
F3 This option award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer prior to the Issuer registering a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended. It is reported herein as a transaction pursuant to Rule 16a-2(a).
F4 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.
F5 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.